Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-37 Cr₹76 Cr₹19 Cr₹155 Cr₹-93 Cr

What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA is ₹-37 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-37 Cr
Mar2024₹76 Cr
Mar2023₹19 Cr
Mar2022₹155 Cr
Mar2021₹-93 Cr

How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-37 Cr
Negative
Mar2024 ₹76 Cr
290.95
Mar2023 ₹19 Cr
-87.48
Mar2022 ₹155 Cr
Positive
Mar2021 ₹-93 Cr -

Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹92,783.0 Cr 9.9% 5.8% -2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

9.9%

5.8%

-2%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses